Pharmacokinetics of the transdermal delivery of benfotiamine.

about

Insights into the percutaneous penetration of antidiabetic agents.

P2860

Q38921153-0567EC95-44F0-4895-BDCB-87952554CCFC

P2860

Pharmacokinetics of the transdermal delivery of benfotiamine.

Item

http://www.wikidata.org/entity/Q46873326

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Pharmacokinetics of the transdermal delivery of benfotiamine.

@en

Pharmacokinetics of the transdermal delivery of benfotiamine.

@nl

type

Item

label

Pharmacokinetics of the transdermal delivery of benfotiamine.

@en

Pharmacokinetics of the transdermal delivery of benfotiamine.

@nl

prefLabel

Pharmacokinetics of the transdermal delivery of benfotiamine.

@en

Pharmacokinetics of the transdermal delivery of benfotiamine.

@nl

P1476

Pharmacokinetics of the transdermal delivery of benfotiamine.

@en

P2093

Gyula Varadi

http://www.w3.org/2001/XMLSchema#string

Stephen G Carter

http://www.w3.org/2001/XMLSchema#string

Zhen Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study.

Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects

Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.

The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial

Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.

Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.

P2888

s00592-015-0776-2

P304

317-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00592-015-0776-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279726678

http://www.w3.org/2001/XMLSchema#string

P698

26141141

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics of the transdermal delivery of benfotiamine.

about

P2860

P2860

Pharmacokinetics of the transdermal delivery of benfotiamine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698